Home [sandbox] K4D COVID-19 Resource Hub Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items On the recommendation of the data safety and monitoring board, @REMAP_CAP is declaring efficacy of #tocilizumab with an OR of 1.87 for benefit on a combination of survival and length of time patients received organ support in ICU, compared with standard care [...]

On the recommendation of the data safety and monitoring board, @REMAP_CAP is declaring efficacy of #tocilizumab with an OR of 1.87 for benefit on a combination of survival and length of time patients received organ support in ICU, compared with standard care [...]

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-11-27

Link:

https://api.zotero.org/groups/2494380/items/3347JHRP?format=atom

Updated:

11/27/2020, 11:16

From feeds:

[sandbox] K4D COVID-19 Resource Hub ยป Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items

Tags:

Authors:

jimwoodhill

Date tagged:

11/27/2020, 16:43

Date published:

11/27/2020, 11:15